Brawn Biotech Limited (BRAWN) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE899B01015
Key metrics
- Market Cap
- ₹7 Cr
- P/E Ratio
- 7.79
- EPS
- 2.89
- Book Value
- 14.46
- P/B Ratio
- 1.56
- ROE
- 21.68%
- ROCE
- -10.34%
- Debt / Equity
- —
- Net Margin
- 5.54%
- Revenue Growth
- 26.09%
- Profit Growth
- 152.31%
- Dividend Yield
- —
- 52W High
- ₹24.37
- 52W Low
- ₹17.71
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Brawn Biotech Limited
Brawn Biotech Limited engages in the trading of pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India.
- Headquarters
- New Delhi, India
- Promoter Holding
- 68.59%
The full Brawn Biotech Limited analysis
Create a free account to open the complete BRAWN deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.